ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 95 filers reported holding ARATANA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $338,000 | +68.2% | 65,450 | +17.4% | 0.00% | – |
| Q1 2019 | $201,000 | -37.2% | 55,750 | +6.7% | 0.00% | – |
| Q4 2018 | $320,000 | +15.1% | 52,250 | +9.9% | 0.00% | – |
| Q3 2018 | $278,000 | +46.3% | 47,550 | +6.3% | 0.00% | – |
| Q2 2018 | $190,000 | -12.8% | 44,750 | -9.3% | 0.00% | – |
| Q1 2018 | $218,000 | -16.2% | 49,350 | 0.0% | 0.00% | – |
| Q4 2017 | $260,000 | -14.2% | 49,350 | 0.0% | 0.00% | – |
| Q3 2017 | $303,000 | -15.1% | 49,350 | 0.0% | 0.00% | – |
| Q2 2017 | $357,000 | +72.5% | 49,350 | +26.1% | 0.00% | – |
| Q1 2017 | $207,000 | -88.5% | 39,150 | -84.4% | 0.00% | -100.0% |
| Q4 2016 | $1,801,000 | -2.0% | 250,850 | +27.8% | 0.00% | 0.0% |
| Q3 2016 | $1,837,000 | +643.7% | 196,250 | +401.3% | 0.00% | – |
| Q2 2016 | $247,000 | +58.3% | 39,150 | +38.1% | 0.00% | – |
| Q1 2016 | $156,000 | -97.6% | 28,350 | -97.6% | 0.00% | -100.0% |
| Q4 2015 | $6,617,000 | -36.3% | 1,185,858 | -3.4% | 0.01% | -33.3% |
| Q3 2015 | $10,386,000 | -42.7% | 1,227,631 | +2.4% | 0.01% | -40.0% |
| Q2 2015 | $18,128,000 | +2.7% | 1,198,958 | +8.8% | 0.02% | +7.1% |
| Q1 2015 | $17,645,000 | -10.6% | 1,102,144 | -0.4% | 0.01% | -12.5% |
| Q4 2014 | $19,727,000 | +66.8% | 1,107,041 | -6.0% | 0.02% | +60.0% |
| Q3 2014 | $11,825,000 | -30.2% | 1,177,769 | +8.5% | 0.01% | -28.6% |
| Q2 2014 | $16,947,000 | -7.1% | 1,085,636 | +10.5% | 0.01% | -12.5% |
| Q1 2014 | $18,243,000 | +79.1% | 982,900 | +84.3% | 0.02% | +77.8% |
| Q4 2013 | $10,185,000 | – | 533,227 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|